Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in Pediatric Immune Thrombocytopenia
NCT04516967Phase 3Completed
- Sponsor
- Sobi
- Start
- Mar 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of avatrombopag in immune thrombocytopenia (ITP), sponsored by Sobi. Started Mar 2021; status: completed.
02
Drugs
avatrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04516967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516967.